3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
6
Frailty
4
Lymphoma
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Prostate Cancer Cured
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Lung Neoplasms
1
HER2 Positive Breast Carcinoma
1
Colorectal Neoplasms
1
Interventions
Docetaxel
158
Prednisone
131
Leuprolide
95
bicalutamide
86
enzalutamide
83
Radiotherapy
80
Goserelin
80
Abiraterone Acetate
76
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
54
Magnetic Resonance Spectroscopy
46
Zoledronic Acid
44
gallium 68 PSMA-11
37
Flutamide
34
abiraterone
32
Estramustine
32
radium Ra 223 dichloride
30
apalutamide
27
Surveys and Questionnaires
26
Gonadotropin-Releasing Hormone
26
Androgen Antagonists
25
cabazitaxel
24
Radiosurgery
24
Dutasteride
22
sipuleucel-T
21
Prednisolone
21
Triptorelin Pamoate
20
Paclitaxel
20
luprolide acetate gel depot
19
Radiation
19
Exercise
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Prostatic Neoplasms
×
Geriatric Assessment
×
Clear all
NCT06125145
2025-12-05
GAP
University of California, Davis
Phase NA
Completed
30 enrolled
NCT02876237
2018-05-31
PROGERAD
Institut Cancerologie de l'Ouest
Phase NA
Completed
230 enrolled